Critical illness induces alternative activation of M2 macrophages in adipose tissue

[1]  S. Gordon,et al.  Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.

[2]  G. Van den Berghe,et al.  Alterations in adipose tissue during critical illness: an adaptive and protective response? , 2010, American journal of respiratory and critical care medicine.

[3]  J. Ochoa,et al.  Nature of myeloid cells expressing arginase 1 in peripheral blood after trauma. , 2009, The Journal of trauma.

[4]  M. Munder.  Arginase: an emerging key player in the mammalian immune system , 2009, British Journal of Pharmacology.

[5]  Isao Usui,et al.  Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice , 2009, Diabetes.

[6]  A. Chawla,et al.  Mechanisms of macrophage activation in obesity-induced insulin resistance , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[7]  J. A. van der Laak,et al.  Peroxisome Proliferator-activated Receptor γ Activation Promotes Infiltration of Alternatively Activated Macrophages into Adipose Tissue* , 2008, Journal of Biological Chemistry.

[8]  G. Van den Berghe,et al.  Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients* , 2008, Critical care medicine.

[9]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[10]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[11]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[12]  P. Buehler,et al.  CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. , 2006, Blood.

[13]  Ilse Vanhorebeek,et al.  Intensive insulin therapy protects the endothelium of critically ill patients. , 2005, The Journal of clinical investigation.

[14]  C. Moinard,et al.  Polyamines: metabolism and implications in human diseases. , 2005, Clinical nutrition.

[15]  F. Brombacher,et al.  Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. , 2004, Immunity.

[16]  Dieter Mesotten,et al.  Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. , 2004, The Journal of clinical endocrinology and metabolism.

[17]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[18]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[19]  S. Ridley,et al.  Drugs in anaesthesia , 2003, Anaesthesia.

[20]  G. Van den Berghe,et al.  Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. , 2003, The Journal of clinical endocrinology and metabolism.

[21]  A. Aljada,et al.  Insulin as an anti-inflammatory and antiatherosclerotic hormone. , 2003, Clinical cornerstone.

[22]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[23]  B. Boulanger,et al.  Arginase I Expression and Activity in Human Mononuclear Cells After Injury , 2001, Annals of surgery.

[24]  S. Moestrup,et al.  Identification of the haemoglobin scavenger receptor , 2001, Nature.

[25]  J. Lehmann,et al.  Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. , 2000, Molecular cell.

[26]  G. Strassmann,et al.  IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes. , 1996, Cellular immunology.

[27]  B. Spiegelman,et al.  15-Deoxy-Δ 12,14-Prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ , 1995, Cell.

[28]  B. Spiegelman,et al.  15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. , 1995, Cell.

[29]  L. Lind,et al.  Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival. , 1994, Clinical intensive care : international journal of critical & coronary care medicine.

[30]  K. Feingold,et al.  Tumor necrosis factor, cytokines, and the hyperlipidemia of infection , 1991, Trends in Endocrinology & Metabolism.